SP

Shilpa Paresh Shah

Active Director Director DIN 05231047
DIN 05231047 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2012
Shareholding value •••• Premium profile

About Shilpa Paresh Shah

Data last updated:

Shilpa Paresh Shah is a Director at Shrim Pharma Private Limited (since 2012). The company operates in Pharma. Shrim Pharma Private Limited reported revenue of ₹3.89 Cr (FY 2025).

DIN 05231047
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2012
Oldest Company Age 14 yrs
Largest company Shrim Pharma Private Limited · ₹3.89 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shrim Pharma Private Limited U52100MH2012PTC228795
Director28 Mar 20122012₹3.89 Cr (FY 2025)Active

Board colleagues of Shilpa Paresh Shah

Directorship timeline

Open interactive timeline →
Shrim Pharma Private Limited
Premium access

Shareholding and investment profile for Shilpa Paresh Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilpa Paresh Shah

Shilpa Paresh Shah currently holds 1 directorship: Shrim Pharma Private Limited (Director, since 28 Mar 2012, revenue ₹3.89 Cr (FY 2025)).

Shilpa Paresh Shah was first appointed on 28 Mar 2012 as Director at Shrim Pharma Private Limited.

The current boards of Shilpa Paresh Shah's companies include Damyanti Vikas Modi (Shrim Pharma Private Limited), Vikas Kanaiyalal Modi (Shrim Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available